While further studies are needed, it is very likely that combined targeting of TGF-β-ERK1/2 and PDGF-BB-Akt axis would be beneficial to suppress PAVSMC hyper-proliferation and remodeling in PAH. Here, TGFB1 is linked to pulmonary arterial hypertension.